Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Achieve Life Sciences Inc (ACHV)
NASDAQ:ACHV
Achieve Life Sciences (ACHV) Stock Price & Analysis
1,031 Followers
ACHV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.03 - $10.30
Previous Close$4.35
Volume114.65K
Average Volume (3M)98.27K
Market Cap
$148.82M
Enterprise Value$150.01M
Total Cash (Recent Filing)$15.55M
Total Debt (Recent Filing)$16.73M
Price to Earnings (P/E)-2.8
Beta1.35
Next Earnings
May 09, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.53
Shares Outstanding34,251,911
10 Day Avg. Volume70,684
30 Day Avg. Volume98,274
Standard Deviation0.26
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-40.45
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-8.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-5.61
Forecast
1Y Price Target
$20.50Price Target Upside360.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Achieve Life Sciences News
Ownership Overview
12.76% Insiders
2.28% Mutual Funds
3.24% Other Institutional Investors
81.73% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACHV FAQ
What was Achieve Life Sciences Inc’s price range in the past 12 months?
Achieve Life Sciences Inc lowest stock price was $3.03 and its highest was $10.30 in the past 12 months.
What is Achieve Life Sciences Inc’s market cap?
Currently, no data Available
When is Achieve Life Sciences Inc’s upcoming earnings report date?
Achieve Life Sciences Inc’s upcoming earnings report date is May 09, 2024 which is in 22 days.
How were Achieve Life Sciences Inc’s earnings last quarter?
Achieve Life Sciences Inc released its earnings results on Mar 28, 2024. The company reported -$0.26 earnings per share for the quarter, beating the consensus estimate of -$0.31 by $0.05.
Is Achieve Life Sciences Inc overvalued?
According to Wall Street analysts Achieve Life Sciences Inc’s price is currently Undervalued.
Does Achieve Life Sciences Inc pay dividends?
Achieve Life Sciences Inc does not currently pay dividends.
What is Achieve Life Sciences Inc’s EPS estimate?
Achieve Life Sciences Inc’s EPS estimate is -$0.23.
How many shares outstanding does Achieve Life Sciences Inc have?
Achieve Life Sciences Inc has 34,251,910 shares outstanding.
What happened to Achieve Life Sciences Inc’s price movement after its last earnings report?
Achieve Life Sciences Inc reported an EPS of -$0.26 in its last earnings report, beating expectations of -$0.31. Following the earnings report the stock price went up 0.881%.
Which hedge fund is a major shareholder of Achieve Life Sciences Inc?
Currently, no hedge funds are holding shares in ACHV
---
Achieve Life Sciences Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.50 (360.67% Upside)
$20.50 (360.67% Upside)
Blogger Sentiment
Bullish
ACHV Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $91.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.7%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.29%
12-Months-Change
Fundamentals
Return on Equity
-869.88%
Trailing 12-Months
Asset Growth
-35.37%
Trailing 12-Months
Company Description
Achieve Life Sciences Inc
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products, cytisine, is a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
---
ACHV Earnings Call
Q4 2024
0:00 / 0:00
---
ACHV Stock 12 Months Forecast
Average Price Target
$20.50
▲(360.67% Upside)
Technical Analysis
Agile Therapeutics
―
Arrowhead Pharmaceuticals
―
Benitec Biopharma
―
Corbus Pharmaceuticals
―
Best Analysts Covering ACHV
1 Year
1 Year Success Rate
7/13 ratings generated profit
1 Year Average Return
+8.37%
reiterated a buy rating 4 months ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of +8.37% per trade.
---